Study: US Lung Cancer Rates Decline
The rates of new lung cancer cases in the US dropped among men in 35 states and among women in 6 states between 1999 and 2008.
Read MorePosted by Clinical Lab Products | Sep 19, 2011 | Cancer, Miscellaneous |
The rates of new lung cancer cases in the US dropped among men in 35 states and among women in 6 states between 1999 and 2008.
Read MorePosted by Clinical Lab Products | Sep 8, 2011 | Cancer, Miscellaneous |
bioTheranostics has published study results related to its 92-gene molecular classification test to aid in the determination of the origin of a tumor.
Read MorePosted by Clinical Lab Products | Sep 6, 2011 | Cancer, Miscellaneous |
Judy O’Rourke We wish we could be across the room, asking what you think about things. Plan B is the recent survey we conducted in partnership with the research department at Mizuho Securities USA, asking where you think personalized med
Read MorePosted by Clinical Lab Products | Sep 3, 2011 | Cancer, Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits, Miscellaneous |
Update on how some companies are embracing personalized medicine in oncology testing
Read MorePosted by Clinical Lab Products | Aug 29, 2011 | Cancer, Miscellaneous |
The new Abbott Vysis ALK Break Apart FISH Probe test is designed to identify ALK-positive NSCLC patients for Pfizer’s approved NSCLC therapy, XALKORI (crizotinib), an oral ALK inhibitor.
Read More